Form 4: KORU Medical Systems Director Donna French Reports Acquisition of Shares
SEC Form 4 Filing
Director Donna French acquired 6,329 shares of KORU Medical Systems at $2.37 per share on March 31, 2024.
Summary
- On March 31, 2024, Donna French, a director of KORU Medical Systems, acquired 6,329 shares of common stock.
- The acquisition price was $2.37 per share.
- Following the transaction, Ms. French beneficially owns 59,979 shares of KORU Medical Systems.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine disclosure of a director purchasing shares, which can be seen as a mildly positive signal, but doesn't provide enough information to strongly influence sentiment.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors seeking to gauge management's sentiment and confidence in the company.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholders if it signals confidence from a company director.
Key Dates
| Date | Description |
|---|---|
| 03/31/2024 | Date of transaction: Acquisition of shares by Donna French |
| 04/01/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.